Glyphic Biotechnologies

Berkeley, CA · Founded 2021 · Privately Held (backing)

Operator of a biotechnology platform intended to increase binding affinity and improve consistency to help create personalized, precision cancer vaccines for patients of all backgrounds. Glyphic Biotechnologies is based in Berkeley, CA and was founded in 2021. Its last reported valuation was $155 million in Sep 2025. It has raised $43.8 million.

Last reported valuation
$155.0M
Oct 2026
Priced at
—
Total raised
$43.8M
Last round
—

Who backs Glyphic Biotechnologies?

35 investors
InvestorType
GaingelsVenture capital
Calm VenturesVenture capital
Valor Equity PartnersGrowth equity
SBXiVenture capital
Johnson & Johnson Innovation - JLABSOther
Wing Venture CapitalVenture capital
Osage University PartnersVenture capital
Arben VenturesVenture capital
Harpoon VCVenture capital
Modi VenturesVenture capital
+ 25 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Glyphic Biotechnologies investors

35 investors are on record for Glyphic Biotechnologies, including Gaingels, Calm Ventures, Valor Equity Partners and SBXi. By type, the record holds 11 venture capital firms and 1 family office.

Free account
More of Glyphic Biotechnologies with a free account
  • ·The complete investor list: 35 names
  • ·Watch Glyphic Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 35 firms already write checks for companies like Glyphic Biotechnologies. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View